Articles related to Pulmonology

AI’s pivotal role in pulmonary embolism diagnosis transforms patient care by achieving remarkable diagnostic efficiency and accuracy, ensuring timely and targeted interventions for those in critical need.

This study underscores the importance of refining and adhering to outpatient management protocols for low-risk acute pulmonary embolism patients. Despite the proven safety and effectiveness of such approaches, only one third of eligible patients were discharged for outpatient care between 2012 and 2020, indicating a significant gap in practice.

Understanding the nuanced criteria for urine antigen testing in Legionella pneumonia—particularly in severe CAP or during outbreaks—can enhance patient outcomes and prevent unnecessary testing costs.

In a comprehensive analysis of COPD patients, the use of gabapentinoids was found to be associated with a 1.39 times higher risk of severe exacerbations requiring hospitalization. This finding underscores the need for cautious prescribing of these medications in the COPD population, considering their potential respiratory risks.

A look into the FDA’s rigorous 2023 drug approval process, including a record number of new medicines and notable rejections. Understanding these trends is essential for anticipating future treatment landscapes.

In the intricate realm of chest X-ray interpretation, AI shines in detecting diseases but falls short in discerning their absence, especially in complex cases. Lead author Dr. Louis Plesner cautions against relying solely on AI, emphasizing the indispensable role of human radiologists.